Physician profile
Karoline Stadelmann
NPI 1205509197
$12,219.64
in general payments reported to CMS, 2019-2025
14 companies · $2,835 in 2025
The $2,835 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,268 · 2022: $670 · 2023: $1,703 · 2024: $5,744 · 2025: $2,835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,840 · Travel and Lodging: $1,075 · Entertainment: $360 · Education: $7.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,839.93 |
| Travel and Lodging | $1,074.75 |
| Entertainment | $359.76 |
| Education | $7.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $3,786.01 | 2024 | |
| Coopervision INC. | $2,867.19 | 2021-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $1,809.06 | 2022-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $931.70 | 2022-2025 | Infuse, Miebo |
| Harrow Eye, LLC | $480.28 | 2024-2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $442.35 | 2023-2025 | Cequa |
| Alcon Vision LLC | $397.41 | 2021-2025 | Eysuvis, Dailies Total1, Total30 |
| Glaukos Corporation | $368.00 | 2023-2024 | Ce-Marked Kxla System, Idose |
| Optos, INC. | $359.76 | 2023-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $274.68 | 2022 | |
| Dompe US, INC. | $197.72 | 2022-2024 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $142.38 | 2024 | Tecnis Iol |
| Abbvie INC. | $103.07 | 2023 | Vuity |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $60.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karoline Stadelmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.